通过导管修复额头门,以治疗初级额头回
Rowa H Attar1, Stephen H Little1, Nadeen N Faza1
1Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX 77030, USA.
Reviews in cardiovascular medicine
|July 30, 2024
概括
过导管边缘到边缘修复 (TEER) 为高风险患者的严重初级额头吐 (MR) 提供了一种最小入侵的选择. 本综述详细介绍了TEER患者选择,程序指导和随访的临床和心声学策略.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 透导管 mitra 修复装置正在快速发展,用于初级 mitra 吐 (MR).
- 超导管边缘到边缘修复 (TEER) 已被批准用于高风险手术候选人的严重初级MR.
- 最佳的患者选择和程序指导对于TEER的成功至关重要.
研究的目的:
- 为TEER提供综合的临床和心声回声学方法.
- 为了指导患者的选择,手术内成像和TEER手术后随访.
- 为了突出未来的跨导管中膜修复的进步.
主要方法:
- 审查关于TEER技术和临床应用的当前文献.
- 为患者管理整合临床评估和心声回声学参数.
- 讨论用于程序内指导和随访的成像方法.
主要成果:
- TEER是针对重症原发性MR患者的精选患者的一种成熟治疗方法.
- 结合临床和心声回声数据的综合方法优化了TEER的结果.
- 持续的技术进步有望扩大跨导管 mitra 修复的应用.
结论:
- TEER代表了在治疗严重的原发性MR病毒方面取得的重大进展.
- 为了成功实施TEER,必须采用多学科的方法.
- 未来的研究将专注于精炼技术和扩大跨导管 mitra 门修复的指示.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
947
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
947
Mitral Regurgitation III: Medical Management
689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Regurgitation IV: Nursing Management
606
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
606
Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538


